LONDON (dpa-AFX) - Hikma Pharmaceuticals plc (HIK, HIK.L) Friday said it received a warning letter from the U.S. Food and Drug Administration on October 23 following the agency's inspection of the Portugal manufacturing facility in March.
Hikma said the FDA raised issues related to investigations and environmental monitoring at the facility.
The company does not expect the warning letter to impact operations of the facility or Hikma's financial outlook for 2014.
Copyright RTT News/dpa-AFX